HOME >> MEDICINE >> NEWS
Adverse Drug Reactions Are Under Reported

(Under reporting of suspected adverse drug reactions to newly marketed ("black triangle") drugs in general practice: observational study)

In this week's BMJ Dr Richard Martin from the Drug Safety Research Unit at Southampton and colleagues from the School of Medicine at the University of Southampton report that general practitioners under-report suspected adverse drug reactions to newly marketed drugs to the Committee on Safety of Medicines. Severe and previously unknown adverse drug reactions to new products are more likely to be reported to the Committee. The authors believe that under-reporting and this bias in reporting needs to be addressed and that doctors should report all adverse reactions, however minor, that their patients have to drugs that have recently been launched onto the market, to enable effective postmarketing surveillance to take place.

Contact:
Dr Richard Martin, Clinical Research Fellow, Drug Safety Research Unit, Southampton


'"/>

Contact: Jill Shepherd
jshepher@bma.org.uk
+44(0)171 383 6529
BMJ-British Medical Journal
10-Jul-1998


Page: 1

Related medicine news :

1. Adverse drug events in nursing homes are far more common than previously identified
2. Adverse events among patients following discharge from hospital
3. More Evidence Of Possible Adverse Effects From New Hormone Use In Women With Heart Disease
4. Scientists To Prepare Advisory Report On Whats Been Learned About The Possible Adverse Health Effects of Electric Fields
5. Beware Of Adverse Drug Reactions
6. Premature Birth Sometimes Can Adversely Affect Infants Ties To Mother
7. New Concepts Proposed To Investigate Drug Reactions
8. Understanding how vulnerabilities may keep women in abusive relationships
9. From town planning to intimate sex: Understanding the risks in our lives
10. Understanding how prostaglandin prevents gut injury during radiation therapy
11. Undertreatment spurs new arrests among drug ofenders diverted under Californias Proposition 36

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Adverse Drug Reactions Are Under Reported

(Date:8/4/2015)... ... August 04, 2015 , ... Seedstock’s 4th ... Nov. 3 – 4, 2015, at UC San Diego, will explore innovations that ... food access, and manage resources efficiently against the dueling backdrop of a lingering ...
(Date:8/4/2015)... ... 2015 , ... Many men are confused about the safety of testosterone replacement ... as a voice of authority for men seeking accurate information about testosterone. , ... and expertise in the safe and effective treatment of low testosterone. In recent years, ...
(Date:8/4/2015)... ... , ... They say a picture is worth a thousand words, and when ... can be essential. StayWell, a health solutions company, announced today it will license KramesArt™ ... used by physicians and other health care providers for more than 40 years and ...
(Date:8/4/2015)... Francisco, Calif. (PRWEB) , ... August 04, 2015 ... ... to corporations, law firms and government entities, today announced that John Munro, a ... team as Vice President of Managed Services Operations. , “I am thrilled to ...
(Date:8/4/2015)... , ... August 04, 2015 , ... ... with full examination now offered by the world renowned Beverly Hills facelift ... facial appearance through cosmetic surgery techniques helps individuals to achieve an outer appearance ...
Breaking Medicine News(10 mins):Health News:Diversity of Urban and Hydroponic Farms of the Future to Highlight Seedstock Annual Conference Field Trip 2Health News:Diversity of Urban and Hydroponic Farms of the Future to Highlight Seedstock Annual Conference Field Trip 3Health News:New Video from Renew Man™ Raises Awareness of the Right Way to Correct Low Testosterone 2Health News:New Video from Renew Man™ Raises Awareness of the Right Way to Correct Low Testosterone 3Health News:StayWell Offers Instant Downloads, Licensing of Medical Art to Improve Patient Education 2Health News:StayWell Offers Instant Downloads, Licensing of Medical Art to Improve Patient Education 3Health News:John Munro Joins eDiscovery Leader Discovia as Vice President of Managed Services Operations 2Health News:John Munro Joins eDiscovery Leader Discovia as Vice President of Managed Services Operations 3Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 2Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 3
(Date:8/4/2015)... , Aug. 4, 2015  ContraVir Pharmaceuticals, ... focused on the development and commercialization of targeted ... Chief Executive Officer, will present live at VirtualInvestorConferences.com ... August 6, 2015 TIME: 12:15PM EDT LINK: ... a live, interactive online event where investors are ...
(Date:8/4/2015)... -- ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP ) ... months ended June 30, 2015 and updated its financial ... conference call this morning, August 4, 2015, at 10:30 ... the call by dialing (855) 582-8078. The conference ID ... Year-to-date net revenues of $38.3 million, an increase of 118% ...
(Date:8/3/2015)... --  The Intellectual Property and Science business of ... intelligent information for businesses and professionals announced the ... Factbook , the biopharmaceutical industry,s leading resource of ... R&D, the analysis identifies a surge in global ... sales to reach $1.3 trillion by 2018. It ...
Breaking Medicine Technology:ContraVir to Webcast Investor Presentation on August 6: VirtualInvestorConferences.com 2ContraVir to Webcast Investor Presentation on August 6: VirtualInvestorConferences.com 3ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 2ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 3ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 4ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 5ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 6ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 7ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 8ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 9ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 10ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 11ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 12ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 13ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 14ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 15ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 16Pharma Sales to Grow Beyond $1 Trillion 2
Cached News: